Ads
related to: minimum oxidation state of cr in cro 3 plus 7 regimen for breast cancer
Search results
Results From The WOW.Com Content Network
4 CrO 3 → 2 Cr 2 O 3 + 3 O 2. It is used in organic synthesis as an oxidant, often as a solution in acetic acid, [9] or acetone in the case of the Jones oxidation. In these oxidations, the Cr(VI) converts primary alcohols to the corresponding carboxylic acids and secondary alcohols to ketones. The reactions are shown below: Primary alcohols ...
A chemotherapy regimen is a regimen for chemotherapy, ... breast cancer: BACOD ... idarubicin x 3 days plus Ara-C x 7 days, a ...
Chromate anions (CrO 2− 4) and dichromate (Cr 2 O 7 2−) anions are the principal ions at this oxidation state. They exist at an equilibrium, determined by pH: 2 [CrO 4] 2− + 2 H + ⇌ [Cr 2 O 7] 2− + H 2 O. Chromium(VI) oxyhalides are known also and include chromyl fluoride (CrO 2 F 2) and chromyl chloride (CrO 2 Cl 2). [6]
Commonly three electrons are added to a chromium atom, reducing it to oxidation state +3. In acid solution the aquated Cr 3+ ion is produced. Cr 2 O 2− 7 + 14 H + + 6 e − → 2 Cr 3+ + 7 H 2 O ε 0 = 1.33 V. In alkaline solution chromium(III) hydroxide is produced. The redox potential shows that chromates are weaker oxidizing agent in ...
"7+3" in the context of chemotherapy is an acronym for a chemotherapy regimen that is most often used today (as of 2014) as first-line induction therapy (to induce remission) in acute myelogenous leukemia, [1] [2] excluding the acute promyelocytic leukemia form, which is better treated with ATRA and/or arsenic trioxide and requires less chemotherapy (if requires it at all, which is not always ...
Potassium chlorochromate is an inorganic compound with the formula KCrO 3 Cl. [4] It is the potassium salt of chlorochromate, [CrO 3 Cl] −. It is a water-soluble orange compound is used occasionally for oxidation of organic compounds. It is sometimes called Péligot's salt, in recognition of its discoverer Eugène-Melchior Péligot.
Ad
related to: minimum oxidation state of cr in cro 3 plus 7 regimen for breast cancer